Douglas Tremblay, MD is an Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Tremblay completed fellowship and residency training at Mount Sinai where he served as both Chief Fellow and Chief Resident. His clinical and translational research focus is on hematologic malignancies, particularly myelodysplastic/myeloproliferative overlap syndromes including chronic myelomonocytic leukemia (CMML) as well as myeloproliferative neoplasms (MPNs) and acute myeloid leukemia. Dr. Tremblay is the Principal Investigator (PI) on numerous investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms. Additionally, he is a participant in the American Society of Hematology Clinical Research Training Institute and holds multiple administrative roles at Mount Sinai.